StoneX Group’s Opko Health OPK Stock Holding History

StoneX Group’s Portfolio OPK Stock Details OPK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-21,599	Closed	-$27.2K	–	1162
2025 Q4	$27.2K	Buy	+21,599	New	+$30.1K	﹤0.01%	960

Other funds holding OPK

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

WCM

Whitefort Capital Management New York $406M AUM 84.26% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

StoneX Group's OPK Position: Q1 2026 in Review

StoneX Group sold out of Opko Health (OPK) in Q1 2026, closing a stake of 21,599 shares — an estimated $27.2K sold.

StoneX Group first reported a position in OPK in Q4 2025 and held it in 1 quarter. The position peaked at $27.2K in Q4 2025. 236 funds tracked by Wall St. Rank hold OPK as of Q1 2026.

StoneX Group reported no remaining Opko Health position as of Q1 2026 after selling out during the quarter.
StoneX Group sold 21,599 Opko Health shares in Q1 2026, an estimated $27.2K.
StoneX Group first reported a position in Opko Health in Q4 2025 and held it in 1 quarter.
StoneX Group's Opko Health position peaked at $27.2K in Q4 2025.
236 funds tracked by Wall St. Rank held Opko Health as of Q1 2026.

Based on StoneX Group's 13F filing for Q1 2026, filed 14 May 2026.